EBEWE Pharma (Generic Injectables Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

EBEWE Pharma (Generic Injectables Business) General Information

Description

Manufacturer of generic oncology medicines. The business unit manufactures generic medicines such as paclitaxel, epirubicin, methotrexate, oxaliplatin, carboplatin, doxorubicin and gemcitabine for the treatment of many types of cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Unterach
  • Austria
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EBEWE Pharma (Generic Injectables Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EBEWE Pharma (Generic Injectables Business)‘s full profile, request access.

Request a free trial

EBEWE Pharma (Generic Injectables Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EBEWE Pharma (Generic Injectables Business)‘s full profile, request access.

Request a free trial